Classes
Publications
- Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA registry2011 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Autologous stem cells transplantation in patient treated for systematic sclerodermia with refraktory interstitial pulmonary process2005 | First Faculty of Medicine, Third Faculty of Medicine
- Hematopoietic stem cell transplatation for multiple scerosis: A retrospective multicenter study2002 | First Faculty of Medicine, Third Faculty of Medicine
- Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis2001 | First Faculty of Medicine, Third Faculty of Medicine
- Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis2000 | Central Library of Charles University
- Reccommendations of accreditation conditions for departments engaged in autologous and allogenic transplantations of blood and bone marrow - recommendations of the Haematological Society and Onkological Society of the Cz|ech J.E. Purkyně Medical Association1997 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine
- Indications for allogenous and autologous transplantations of blood and bone marrow1997 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine
- Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions2024 | Third Faculty of Medicine, Central Library of Charles University
- Cognitive impairment associated with Hodgkin's lymphoma and chemotherapy2023 | First Faculty of Medicine, Third Faculty of Medicine
- Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis2023 | First Faculty of Medicine, Third Faculty of Medicine
Loading network view...